SEC Form 4 · accession 0000899243-16-022678
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard K Prins
Director
Period of report
Jun 9, 2016
Accepted (ET)
Jun 13, 2016 · 8:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 9, 2016 | A | 6,086 | $0.00 | A | 29,086 | D | |
| Common Stock | Jun 13, 2016 | M | 7,500 | $14.23 | A | 36,586 | D | |
| Common StockF2 | Jun 13, 2016 | S | 7,500 | $15.9381 | D | 29,086 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $16.43 | Jun 9, 2016 | A | 25,827 | A | — | Jun 9, 2021 | Common Stock | 25,827 | 25,827 | D |
| Stock Option (right to buy)F4 | $14.23 | Jun 13, 2016 | M | 7,500 | D | — | Dec 10, 2016 | Common Stock | 7,500 | 3,898 | D |
Explanation of responses
- F1The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 9, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.88 to $15.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F3All of the shares subject to the option vest on June 9, 2017.
- F4Shares subject to the option are fully vested and immediately exercisable.